VR Logo

Alkem Laboratories Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1973

Chairman: Basudeo N Singh

Managing Director: Sandeep Singh

Group: --

Listing: NSE: ALKEM, BSE: 539523

Headquarters: Mumbai, Maharashtra

Website: www.alkemlabs.com

Key Facts

Market cap: R 34,554.29 Cr

Revenue (TTM): R 8,498.35 Cr

Earnings (TTM): R 1,385.21 Cr

Cash: R 1,262.10 Cr

Total Debt: R 1,700.85 Cr

Promoters' ownership: 62.43%

Liquidity: High

52 Week range: R 1,708.00 - 3,090.00

Face value: R2.00

Shares outstanding: 11,95,65,000

10 Years Aggregate:

  • CFO: 3,153.21 Cr
  • EBITDA: 7,305.31 Cr
  • Net Profit: 6,130.43 Cr

Stock Performance

Time Period Alkem Laboratories S&P BSE Healthcare S&P BSE Mid Cap
YTD47.8746.26-3.66
1 month22.9418.537.64
3 months15.0728.6226.23
1 Year68.4854.375.46
3 Years19.8615.39-0.76
5 Years--2.334.52
10 Years--13.466.63
As on 10-Aug-2020
Year Alkem Laboratories S&P BSE Mid Cap S&P BSE Healthcare
20193.79-3.05-3.55
2018-11.42-13.31-5.89
201735.2048.130.49
20168.357.97-12.88